1 of 5
2 of 5
3 of 5
4 of 5
5 of 5
Polyclonal Rabbit anti‑Human Ghrelin Antibody (RPE, IHC, IF, WB) LS‑C773229
Polyclonal Rabbit anti‑Human Ghrelin Antibody (RPE, IHC, IF, WB) LS‑C773229
Antibody:
Ghrelin Rabbit anti-Human Polyclonal (RPE) Antibody
Format:
R. Phycoerythrin, Unmodified
Overview
Antibody:
Ghrelin Rabbit anti-Human Polyclonal (RPE) Antibody
Format:
R. Phycoerythrin, Unmodified
Specifications
Description
Ghrelin antibody LS-C773229 is an RPE-conjugated rabbit polyclonal antibody to Ghrelin from human. It is reactive with human and rat. Validated for IF, IHC and WB.
Reactivity
Human, Rat
(tested or 100% immunogen sequence identity)
Conjugations
R. Phycoerythrin.
Also available conjugated with
AP,
APC,
Atto 390,
Atto 488,
Atto 594,
Biotin,
FITC,
PerCP.
Purification
Peptide Affinity Purified
Immunogen
Synthetic peptide from the mid-protein of Human Ghrelin
Specificity
Detects ~13 kDa.
Applications
- IHC (1:50)
- Immunofluorescence (1:100)
- Western blot (1:1000)
- Applications tested for the base form of this product only
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
PBS, 0.09% Sodium Azide, 50% Glycerol
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human
Applications:
ELISA
Species:
Human
Applications:
Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/27/2024